This discrepancy could be due to the different experimental approaches used in these studies, including the use of different insulin infusion rates during hyperinsulinaemic euglycaemic clamps (HEC) or differences in the degree of obesity or glycaemic status of the subjects. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.